Effect of salmeterol/fluticasone (SM/FP) on inflammatory factors in children with bronchial asthma
10.3969/j.issn.1005-1678.2016.04.17
- VernacularTitle:沙美特罗丙酸氟替卡松干粉对支气管哮喘炎症因子的影响
- Author:
Lan LI
;
Yuan ZHANG
;
Yonglin LIU
;
Yongqin ZHU
;
Yu REN
- Publication Type:Journal Article
- Keywords:
salmeterol/fluticasone ( SM/FP);
children;
bronchial asthma;
T-lymphocyte subsets;
IL-2;
IL-4;
IFN-γ
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):64-65,68
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of salmeterol/fluticasone (SM/FP) on serum inflammatory factors in the treatment of bronchial asthma in children.Methods 80 children with bronchial asthma from January 2015 to October 2015 in department of pediatrics of first affiliated hospital of Zhejiang Chinese medicine university were selected and randomly divided into two groups.The control group were given routine clinical treatment, the experimental group were treated on the basis of the control group with salmeterol/fluticasone (SM/FP), for 4 weeks.The serum IL-2, IL-4, IFN-α, T-lymphocyte subsets and clinical efficacy between the two groups were compared.Results Compared with control group, the serum levels of IL-2 and IFN-γin experimental group were higher, IL-4 in experimental group was lower ( P <0.05 ); the serum CD3 +T, CD4 +T and CD4 +T /CD8 +T levels in experimental group were higher, the serum CD8 +T was lower than those in control group (P<0.05); the total efficiency of the experimental group (92.5%) was significantly higher than that of control group (75.0%) (P<0.05).Conclusion The salmeterol/fluticasone (SM/FP) has the good efficacy in the treatment of bronchial asthma in children, which could effectively regulate T lymphocyte subsets proportion and the level of cytokines.
